CARISOPRODOL AND ASPIRIN Drug Patent Profile
✉ Email this page to a colleague
When do Carisoprodol And Aspirin patents expire, and what generic alternatives are available?
Carisoprodol And Aspirin is a drug marketed by Chartwell Rx, Genus, Novast Labs, and Oxford Pharms. and is included in four NDAs.
The generic ingredient in CARISOPRODOL AND ASPIRIN is aspirin; carisoprodol. There are twenty-two drug master file entries for this compound. Additional details are available on the aspirin; carisoprodol profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for CARISOPRODOL AND ASPIRIN?
- What are the global sales for CARISOPRODOL AND ASPIRIN?
- What is Average Wholesale Price for CARISOPRODOL AND ASPIRIN?
Summary for CARISOPRODOL AND ASPIRIN
| US Patents: | 0 |
| Applicants: | 4 |
| NDAs: | 4 |
| DailyMed Link: | CARISOPRODOL AND ASPIRIN at DailyMed |
US Patents and Regulatory Information for CARISOPRODOL AND ASPIRIN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chartwell Rx | CARISOPRODOL AND ASPIRIN | aspirin; carisoprodol | TABLET;ORAL | 089594-001 | Mar 31, 1989 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Oxford Pharms | CARISOPRODOL AND ASPIRIN | aspirin; carisoprodol | TABLET;ORAL | 040252-001 | Dec 10, 1997 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Genus | CARISOPRODOL AND ASPIRIN | aspirin; carisoprodol | TABLET;ORAL | 040116-001 | Apr 25, 1996 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Novast Labs | CARISOPRODOL AND ASPIRIN | aspirin; carisoprodol | TABLET;ORAL | 040832-001 | Jan 7, 2010 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
